Cargando…
HGUE-C-1 is an atypical and novel colon carcinoma cell line
BACKGROUND: Colorectal carcinoma is a common cause of cancer. Adjuvant treatments include: 5-fluorouracil administered together with folinic acid, or more recently, oral fluoropyrimidines such as capecitabine, in combination with oxaliplatin or irinotecan. Metastatic colorectal cancer patients can b...
Autores principales: | Grasso, Silvina, Martínez-Lacaci, Isabel, Barberá, Víctor Manuel, Castillejo, Adela, Soto, José Luis, Gallego-Plazas, Javier, López-Riquelme, Natividad, García-Morales, Pilar, Mata-Balaguer, Trinidad, Ferragut, José Antonio, Saceda, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394422/ https://www.ncbi.nlm.nih.gov/pubmed/25885658 http://dx.doi.org/10.1186/s12885-015-1183-3 |
Ejemplares similares
-
Dual regulation of P-glycoprotein expression by Trichostatin A in cancer cell lines
por: Balaguer, Trinidad Mata, et al.
Publicado: (2012) -
Resistance to Selumetinib (AZD6244) in Colorectal Cancer Cell Lines is Mediated by p70S6K and RPS6 Activation()
por: Grasso, Silvina, et al.
Publicado: (2014) -
The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study
por: Castillejo, Adela, et al.
Publicado: (2009) -
The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study
por: Castillejo, Adela, et al.
Publicado: (2009) -
Comparative Study of 17-AAG and NVP-AUY922 in Pancreatic and Colorectal Cancer Cells: Are There Common Determinants of Sensitivity?()
por: Mayor-López, Leticia, et al.
Publicado: (2014)